Ebronucimab (Anti-PCSK9)
Product Specifications
CAS Number
2304800-90-4
Synonyms
AK102
Target
PCSK9
Applications
Metabolism
Additionnal Information
Ebronucimab (Anti-PCSK9) is a fully human immunoglobulin G1 (IgG1) monoclonal antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9) used to treat hyperlipidemia. MW : 144.76 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog